Cargando…
Soluble Interleukin-2 Receptor/White Blood Cell Ratio Reflects Granulomatous Disease Progression in Common Variable Immune Deficiency
Autores principales: | van Stigt, Astrid C., Dalm, Virgil A. S. H., Nagtzaam, Nicole M. A., van Hagen, P. Martin, Dik, Willem A., IJspeert, Hanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661782/ https://www.ncbi.nlm.nih.gov/pubmed/37542638 http://dx.doi.org/10.1007/s10875-023-01560-1 |
Ejemplares similares
-
Soluble Interleukin-2 Receptor Is a Promising Serum Biomarker for Granulomatous Disease in Common Variable Immune Deficiency
por: van Stigt, Astrid C., et al.
Publicado: (2021) -
What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review
por: van Stigt, Astrid C., et al.
Publicado: (2020) -
Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis
por: Eurelings, Laura E. M., et al.
Publicado: (2019) -
A Novel Heterozygous Mutation in the STAT1 SH2 Domain Causes Chronic Mucocutaneous Candidiasis, Atypically Diverse Infections, Autoimmunity, and Impaired Cytokine Regulation
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2017) -
Macrophage-fibroblast interplay: a target for neuropeptide-based treatment of fibrotic disease?
por: Virakul, Sita, et al.
Publicado: (2012)